Jason J. Luke, MD, FACP, an associate professor of medicine in the Division of Hematology/Oncology and director of the Cancer Immunotherapeutics Center Immunology and Immunotherapy Program at the University of Pittsburgh Medical Center Hillman Cancer Center, discusses the role of targeted therapy in melanoma.
Archive | Video Reports
Dr. Luke on the Role of Targeted Therapy in Melanoma
Posted in Melanoma News, Health Professionals, Video Reports
Dr. Garutti on the Potential Shift to Neoadjuvant Therapy in Melanoma
Mattia Garutti, MD, medical oncologist, Unit of Clinical Oncology, Centro di Riferimento Oncologico di Aviano, Aviano, Italy, discusses the potential shift to neoadjuvant therapy in melanoma.
Posted in Melanoma News, Health Professionals, Video Reports
Dr. Shoushtari on the Design of the CheckMate-067 Trial in Advanced Melanoma
Alexander N. Shoushtari, MD, an assistant attending physician at Memorial Sloan Kettering Cancer Center, discusses the design of the ?phase 3 CheckMate-067 trial in advanced melanoma.
Posted in Melanoma News, Health Professionals, Video Reports
Dr. Eggermont on the Rationale for Evaluating Adjuvant Pembrolizumab in Advanced Melanoma
Alexander M. M. Eggermont, MD, PhD, professor of oncology, University of Paris-Sud, professor of oncological surgery, chair, International Research Network on Cancer, Erasmus University of Rotterdam, Joseph Maisin Honorary Chair of Oncological Surgery, Louvain Catholic University, discusses the rationale for the phase 3 EORTC 1325/KEYNOTE-054 trial, ?evaluating adjuvant pembrolizumab (Keytruda) versus placebo, in advanced melanoma.
Posted in Melanoma News, Health Professionals, Video Reports
